These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3780130

  • 1. Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension.
    Drayer JI, Hall WD, Smith VE, Weber MA, Wollam GL, White WB.
    Clin Pharmacol Ther; 1986 Dec; 40(6):679-85. PubMed ID: 3780130
    [Abstract] [Full Text] [Related]

  • 2. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA, Drayer JI.
    J Cardiovasc Pharmacol; 1984 Dec; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [Abstract] [Full Text] [Related]

  • 3. Prolonged calcium channel blocker therapy of hypertension.
    Weber MA.
    J Cardiovasc Pharmacol; 1988 Dec; 12 Suppl 4():S16-21. PubMed ID: 2468864
    [Abstract] [Full Text] [Related]

  • 4. Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension.
    Giles TD, Sander GE, Roffidal LC, Thomas MG, Given MB, Quiroz AC.
    Am J Cardiol; 1987 Jul 01; 60(1):103-6. PubMed ID: 3300241
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
    Massie BM.
    J Cardiovasc Pharmacol; 1988 Jul 01; 12 Suppl 4():S55-8. PubMed ID: 2468874
    [Abstract] [Full Text] [Related]

  • 6. Long-term antihypertensive effects and safety of nitrendipine in patients with mild, moderate, and severe hypertension.
    Kann J.
    J Clin Pharmacol; 1987 Dec 01; 27(12):945-50. PubMed ID: 3437066
    [Abstract] [Full Text] [Related]

  • 7. Effect of antihypertensive treatment with nitrendipine on left ventricular mass and diastolic filling in patients with mild to moderate hypertension.
    Modena MG, Mattioli AV, Parato VM, Mattioli G.
    J Cardiovasc Pharmacol; 1992 Jan 01; 19(1):148-53. PubMed ID: 1375682
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK, McMahon FG, Ryan JR, Maronde R, Vlachakis N, Mroczek W.
    J Cardiovasc Pharmacol; 1984 Jan 01; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [Abstract] [Full Text] [Related]

  • 9. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
    Machnig T, Henneke KH, Engels G, Pongratz G, Schmalzl M, Gellert J, Bachmann K.
    Cardiology; 1994 Jan 01; 85(2):101-10. PubMed ID: 7954561
    [Abstract] [Full Text] [Related]

  • 10. Comparison and additivity of nitrendipine and hydrochlorothiazide in systemic hypertension.
    Massie BM, Tubau JF, Szlachcic J, Vollmer C.
    Am J Cardiol; 1986 Sep 30; 58(8):16D-19D. PubMed ID: 3532749
    [Abstract] [Full Text] [Related]

  • 11. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec 30; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 12. Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
    Faulhaber HD, Gruner R, Homuth V, Naumann E, Menz M, Hartrodt W, Schmidt J, Mohnike W.
    J Cardiovasc Pharmacol; 1988 Dec 30; 12 Suppl 4():S146-8. PubMed ID: 2468860
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of a new calcium antagonist in severe hypertension.
    Burris JF, Santangelo RP, Mroczek WJ.
    J Clin Pharmacol; 1986 Dec 30; 26(8):593-7. PubMed ID: 3793949
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term efficacy and safety of nitrendipine in severe essential hypertension.
    Burris JF, Nash DT, Mroczek WJ.
    J Cardiovasc Pharmacol; 1988 Dec 30; 12 Suppl 4():S157-60. PubMed ID: 2468863
    [Abstract] [Full Text] [Related]

  • 16. Comparison of nitrendipine with propranolol and its use in combined cardiovascular therapy.
    McMahon FG.
    Am J Cardiol; 1986 Sep 30; 58(8):8D-11D. PubMed ID: 3532752
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B, Nalbantgil S, Yilmaz H, Zoghi M, Ozerkan F, Nalbantgil I, Onder R.
    Saudi Med J; 2004 Dec 30; 25(12):1975-8. PubMed ID: 15711679
    [Abstract] [Full Text] [Related]

  • 19. Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imaging.
    Gaudio C, Tanzilli G, Ferri FM, Villatico Campbell S, Bertocchi F, Motolese M, Campa PP.
    J Cardiovasc Pharmacol; 1998 Nov 30; 32(5):760-8. PubMed ID: 9821850
    [Abstract] [Full Text] [Related]

  • 20. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E, Muiesan ML, Rizzoni D, Romanelli G, Beschi M, Castellano M.
    J Cardiovasc Pharmacol; 1991 Nov 30; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.